- Home
- ESPR vs MIY Comparison
ESPR vs MIY Comparison
Compare ESPR & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- MIY
- Stock Information
- Founded
- ESPR 2008
- MIY 1992
- Country
- ESPR United States
- MIY United States
- Employees
- ESPR N/A
- MIY N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- MIY Investment Bankers/Brokers/Service
- Sector
- ESPR Health Care
- MIY Finance
- Exchange
- ESPR Nasdaq
- MIY Nasdaq
- Market Cap
- ESPR 410.2M
- MIY 340.0M
- IPO Year
- ESPR 2013
- MIY N/A
- Fundamental
- Price
- ESPR $1.89
- MIY $11.67
- Analyst Decision
- ESPR Buy
- MIY
- Analyst Count
- ESPR 6
- MIY 0
- Target Price
- ESPR $7.25
- MIY N/A
- AVG Volume (30 Days)
- ESPR 5.1M
- MIY 56.8K
- Earning Date
- ESPR 02-25-2025
- MIY 01-01-0001
- Dividend Yield
- ESPR N/A
- MIY 3.98%
- EPS Growth
- ESPR N/A
- MIY N/A
- EPS
- ESPR N/A
- MIY N/A
- Revenue
- ESPR $295,451,000.00
- MIY N/A
- Revenue This Year
- ESPR $186.04
- MIY N/A
- Revenue Next Year
- ESPR $11.25
- MIY N/A
- P/E Ratio
- ESPR N/A
- MIY N/A
- Revenue Growth
- ESPR 187.12
- MIY N/A
- 52 Week Low
- ESPR $1.58
- MIY $9.45
- 52 Week High
- ESPR $3.94
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- ESPR 39.38
- MIY 60.53
- Support Level
- ESPR $1.71
- MIY $11.39
- Resistance Level
- ESPR $2.26
- MIY $11.67
- Average True Range (ATR)
- ESPR 0.14
- MIY 0.14
- MACD
- ESPR -0.01
- MIY 0.04
- Stochastic Oscillator
- ESPR 33.33
- MIY 83.33
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from federal and Michigan income taxes.